Fixed-duration epcoritamab in combination with bendamustine + rituximab for first-line treatment of follicular lymphoma: Initial results from EPCORE NHL-2 Arm 3 Meeting Abstract
| Authors: | Brody, J.; Falchi, L.; Vitolo, U.; Nijland, M.; Offner, F.; Snauwaert, S.; Patah, P.; Marek, J.; Morehouse, C.; Steele, A. J.; Hao, Y.; Hoehn, D.; Linton, K. |
| Abstract Title: | Fixed-duration epcoritamab in combination with bendamustine + rituximab for first-line treatment of follicular lymphoma: Initial results from EPCORE NHL-2 Arm 3 |
| Meeting Title: | 66th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 144 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2024 Dec 7-10 |
| Meeting Location: | San Diego, CA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2024-11-05 |
| Start Page: | 1627 |
| Language: | English |
| ACCESSION: | WOS:001412807600032 |
| DOI: | 10.1182/blood-2024-200369 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract -- Source: Wos |
